Ebola is a preventable disease, and yet a safe and effective vaccine has not been deployed. As with many vaccines, financial barriers persist: pharmaceutical companies see high costs with limited market potential, and government ...
Aug 3, 2015
1
53
Researchers from Griffith University's Institute for Glycomics, together with the Nationwide Children's Hospital in Ohio, have uncovered groundbreaking evidence to help vaccine developers prevent middle ear infections.
Jul 29, 2015
0
8
In a scientific discovery that has significant implications for preventing HIV infections, researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham) have identified a protein that could improve the body's ...
Jun 4, 2015
0
28
A consortium of academic and industry organizations led by a team from the Vaccine and Immunotherapy Center (VIC) at Massachusetts General Hospital (MGH) has launched a new effort to develop an entirely new type of vaccine ...
Jun 4, 2015
0
12
Griffith University's Institute for Glycomics has developed a groundbreaking, combination vaccine that may finally beat Streptococcus A infections.
Jun 1, 2015
0
185
A recent study with Kansas State University researchers details vaccine development for two new strains of avian influenza that can be transmitted from poultry to humans. The strains have led to the culling of millions of ...
May 21, 2015
0
21
War and disease have marched arm in arm for centuries. Wars magnify the spread and severity of disease by disrupting populations. As large groups of people move across borders, they introduce and encounter disease in new ...
May 8, 2015
0
9
Researchers at the University of Georgia have used a virus commonly found in dogs as the foundation for a new vaccine against H7N9 influenza, more commonly known as bird flu.
May 6, 2015
0
144
A team of leading international scientists on Tuesday called for new Ebola vaccines to be made available in months rather than years and warned against complacency after a reduction in infection rates.
Feb 17, 2015
0
3
The antibody response from an HIV vaccine trial in Thailand was made possible by a genetic trait carried over in humans from an ancient ancestry with monkeys and apes, according to a study led by Duke Medicine researchers.
Jan 16, 2015
1
12
